Navigation Links
Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment
Date:9/18/2008

idence for physicians and patients regarding HUMIRA's ability to clear the frequently-painful skin lesions associated with psoriasis," said Rebecca Hoffman, M.D., divisional vice president, Immunology, Abbott. "Abbott is committed to continuing research into HUMIRA's optimal use in psoriasis and other therapeutic areas."

About the REVEAL Trial

The REVEAL study was a 52-week, double blind, randomized, placebo-controlled Phase III trial to evaluate the efficacy and safety of HUMIRA in 1,212 patients with moderate to severe chronic psoriasis in the United States and Canada.

About Psoriasis

Psoriasis affects an estimated 125 million people worldwide. The severity of the disease varies from person to person with approximately 25 percent of people with psoriasis experiencing moderate to severe disease.

Psoriasis can develop anywhere on the skin and most commonly appears on the scalp, knees, elbows, lower back, hands and feet. It may even occur in the fingernails and toenails. While psoriasis occurs in people of all ages, it typically first appears in people between the ages of 15 and 25.

Psoriasis can be a very isolating disease and people with psoriasis may suffer from poor self-image, depression and an increased risk of premature death.

Important Safety Information

Globally, prescribing information varies; refer to the individual country product label for complete information.

Serious infections, sepsis, rare cases of tuberculosis (TB), and opportunistic infections, including fatalities, have been reported with the use of TNF antagonists, including HUMIRA. Many of the serious infections have occurred in patients on concomitant immunosuppressive therapy that, in addition to their underlying disease could predispose them to infections. Patients must be monitored closely for infections, including tuberculosis, before, during and after treatment with HUMIRA. Treatment should not be initiated in patients with act
'/>"/>

SOURCE Abbott
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
2. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
3. Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
4. Echo Therapeutics Announces Positive Results with the Prelude(TM) SkinPrep System, the Next-Generation Skin Permeation Medium for its Symphony(TM) Transdermal Continuous Glucose Monitoring System
5. EntreMed Commences Continuous Dosing Clinical Trial For MKC-1
6. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
7. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
8. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
9. S*BIO Initiates U.S. Phase I Clinical Trials of Oral JAK2 Inhibitor SB1518 for the Treatment of Hematological Malignancies
10. Omeros and The Parkinsons Institute and Clinical Center Enter into a Collaboration Agreement to Evaluate Novel Target for the Treatment of Movement Disorders
11. Keraderm to Release $100 Phototherapy Treatment for Fungal Nail Infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)...  When Ryan Rendino first felt the ... neck, he figured it was a muscle ... from weight lifting. But the ... A series of doctor appointments followed ... Michel Kliot, MD , a Northwestern ...
(Date:5/21/2015)... 2015  CryoLife, Inc. (NYSE: CRY ), a ... cardiac and vascular surgery, announced today that its Board ... the second quarter 2015 of $0.03 per share of ... per share will be paid on June 19, 2015 ... 12, 2015.  The ex-dividend date for the quarterly dividend ...
(Date:5/21/2015)... Mai 2015 Dipexium Pharmaceuticals, ... Unternehmen für Arzneimittel im fortgeschrittenen Entwicklungsstadium, ... Vermarktung von Locilex® (Pexiganan-Creme 0,8 %) und ... wissenschaftliche Posterpräsentation an, welche das innovative ... OneStep-1 und OneStep-2, in der Locilex® ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... a global leader in minimally invasive cryotherapy treatments for ... establishing its new Global Headquarters in Minneapolis, MN. ... in Arden Hills during the fourth quarter of 2009. ... functions, the company will also locate its global marketing, ...
... alternative therapy for Parkinson,s , NEW YORK, Sept. 30 ... Center have reached a milestone in the development of potential ... of current therapy. , The team, which received an MJFF ... LEAPS (Linked Efforts to Accelerate Parkinson,s Solutions) initiative, ...
Cached Medicine Technology:Galil Medical Announces Establishment of Global Headquarters in Minneapolis, MN 2Michael J. Fox Foundation-Funded Team Pursuing Glutamate-Based Treatment for Parkinson's Disease Hits Major Milestone 2
(Date:5/24/2015)... Indiana Fiber Network, LLC (IFN), the ... of America, Inc. (MTA) has selected IFN as a ... IFN Enterprise Sales Manager, fiber route diversity and network ... transport provides MTA with the diverse fiber transport from ... Internet and voice carriers located at Henry Street in ...
(Date:5/23/2015)... On May 13, Nithyananda Yoga Foundation organized ... power learned through meditation and initiation at Special Holistic ... , Yogamaatha, a nine-year-old girl from North Carolina, stunned ... attending the 2015 Business Advocacy Summit at Capitol Hill ... , In a demonstration that lasted three hours, Yogamaatha ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 Manufacturers are now ... Performance Factor (HSPF) of 8.2. Experts in the field agree ... benefit consumers. , The HSPF score is what miles per ... more efficient the unit. Although the minimum HSPF score has ... heaters with an HSPF score north of 12. Indeed, the ...
(Date:5/22/2015)... Calif. (PRWEB) May 22, 2015 ... technology, communication and capacity are intersecting to create ... across society, the opening speaker at WesternU's 34th ... California Lieut. Gov. Gavin Newsom, a former San ... the keynote speaker at the graduation ceremony for ...
(Date:5/22/2015)... New York (PRWEB) May 22, 2015 ... ) filed on behalf of individuals who allegedly ... to its use continue to move forward in ... According to a Pretrial Order dated May 4, ... preservation of documents and electronically stored information. Among ...
Breaking Medicine News(10 mins):Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:Parker & Sons Welcomes the Department of Energy’s Water Heater Regulation 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 2Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 3Health News:Court Overseeing Federal Xarelto Lawsuits Establishes Procedures Governing Preservation of Documents, Electronically Stored Information 4
... finds no connection between the two , , MONDAY, Jan. ... of evidence that rejects the idea that immunizations boost ... incidences of the disorder dropped after makers of most ... products. , Researchers found that autism rates in California ...
... prescriptions for children and adults , , MONDAY, Jan. 7 ... thoughts and behaviors in young people who take antidepressants ... research suggests. , The U.S. Food and Drug Administration ... selective serotonin reuptake inhibitors (SSRIs) might increase the risk ...
... for Emageon presentation, BIRMINGHAM, Ala., Jan. 7 ... in enterprise medical information technology,systems for hospitals, healthcare ... Chairman, CEO and President, will present at the,26th ... January 7-10, 2008,at the Westin St. Francis Hotel ...
... PARK, Calif., Jan. 7 ForSight Labs, LLC announced,today ... VISION3,Inc. with a Series A financing of $6 million, ... the medical technology arena: Morgenthaler,Ventures, Split Rock Partners and ... a significant round of funding to,develop our next innovative ...
... Va., Jan. 7 Specialty Blades, Inc. and ... completed its,acquisition of Popper and Sons, Inc. The ... tubing medical device manufacturing company,makes the combined company ... for the medical device industry. Specialty Blades,originally announced ...
... kept exam dates, study finds , , MONDAY, Jan. 7 ... time in the short-term, people who do so tend not ... Time saved with an Internet purchase may translate into ... that people purchasing lenses from wholesale clubs or optical chains ...
Cached Medicine News:Health News:Study Casts Doubt on Vaccine-Autism Link 2Health News:Study Casts Doubt on Vaccine-Autism Link 3Health News:Youth Suicide Warnings Are Slowing Antidepressant Sales 2Health News:ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding 2Health News:ForSight Labs, LLC Announces Formation of Its Third Company, ForSight VISION3, Inc. and Closing of $6 Million in Series A Funding 3Health News:Eye Care Lacking in Many Who Buy Contact Lenses Online 2
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
... The Stryker Cross-Screw System offers ... secure method for ACL reconstruction ... Stryker Cross-Screw System provides the ... The implant comes in Titanium ...
The Stryker Bioabsorbable Wedge Interference Screw is made of Poly-L Lactic Acid (PLLA). The patented wedge design makes it perfect for cruciate reconstruction and is indicated for BTB and soft tissu...
The Stryker Shoulder Instrumentation Set is ideal for open and arthroscopic shoulder procedures. The kit includes all the necessary tools for bone and tissue preparation as well as suture management ...
Medicine Products: